Meyka Pro banner
Becton, Dickinson and Company

Becton, Dickinson and Company (BDXA) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

BDXANYSE
HealthcareMedical - Instruments & Supplies
$59.24
$1.36(2.24%)
U.S. Market opens in 14h 25m

Becton, Dickinson and Company (BDXA)

Meyka AI Score

Z

Key Financials

Market Cap55.9B
P/E Ratio39.58
EPS (TTM)$1.30
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

BDXA Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Becton, Dickinson and Company (NYSE: BDXA) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Becton, Dickinson and Company's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BDXA on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NYSE listing.

Key metrics behind Becton, Dickinson and Company's NYSE-traded stock include a P/E ratio of 39.58 and a market capitalization of 55.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BDXA on the NYSE.

Price Performance (NYSE: BDXA)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-1.58%
5-Year Change
2.14%
All-Time (Max) Change
13.49%

Contact Information

201 847 6800
1 Becton Drive, Franklin Lakes, NJ, 07417-1880

Company Facts

720,000 Employees
IPO DateMay 11, 2017
CountryUS

Frequently Asked Questions